We have developed a multidisciplinary global consortium of researchers who can provide independent high-quality evidence regarding the scale of illicit drug use, harms, access to services at country, regional and global levels, and build capacity for better data in these areas.
Over the past few years, there has been a significant increase in the number of seizures and unintentional overdose fatalities related to illicit synthetic opioids in multiple states across the U.S.
NDARC has been invited to undertake research in partnership with NSW Aboriginal drug and alcohol Residential Rehabilitation Services. This research is unique in being embedded into the routine delivery of their services.
Substance use among pregnant women is a significant public health issue. A range of adverse effects have been noted including increased risk of miscarriage and still birth, reduction in fetal growth, birth defects, developmental delay, growth retardation and neurological abnormalities.
Substance use amongst adolescents (those in the age group of 10-19) is an important public health issue in many countries of the region.
Overdose is a common event in the lives of opioid users, and is the leading cause of death in this population. Overdose risk is particularly elevated during the 4 weeks following release from prison.
The rapidity of overdose and death is of major clinical importance. Essentially, is there time to intervene, or are such deaths typically so rapid as to preclude meaningful intervention? The presence of 6-monoacetly-morphine (6MAM) is indicative of a rapid death following heroin administration.
Compulsive hoarding is a debilitating disorder. Little is known of the substance use of hoarders, or the circumstances in which they die.
This study aimed to examine the feasibility of agonist maintenance treatment for the major psychoactive drug classes: opioids, nicotine, benzodiazepines, cannabis, psychostimulants and alcohol.
The ‘Child protection and mothers in substance abuse treatment study’ was the first study to interview a relatively large sample of women in opioid pharmacological treatment in NSW about their children, parenting and child protection system involvement.
